Clinical Trials Browser

Interventional × Glioblastoma × Surveys and Questionnaires × Clear all

Brain Neoplasms, Glioblastoma

NCT01782976 2018-01-19

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Phase 2 Withdrawn

CNS

Glioblastoma, Recurrence

NCT00376818 2012-06-04

Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

Phase NA Completed

4 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Clinical Trials

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers